Impairment of Quality of Life among Patients with Wearable Cardioverter Defibrillator Therapy (LifeVest®): A Preliminary Study

BACKGROUND: Wearable cardioverter defibrillator (WCD) therapy is feasible and safe in patients as a transient protection against sudden cardiac death (SCD). However, the impact of WCD therapy on quality of life (QoL) has not been studied. METHODS: In our single-centre study, 109 consecutive patients...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biomed Res Int
Glavni autori: Lackermair, Korbinian, Schuhmann, Christoph G., Kubieniec, Michaela, Riesinger, Lisa M., Klier, Ina, Stocker, Thomas J., Kääb, Stefan, Estner, Heidi L., Fichtner, Stephanie
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6040298/
https://ncbi.nlm.nih.gov/pubmed/30050939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6028494
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items